Luis Vicioso
Overview
Explore the profile of Luis Vicioso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
400
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carrillo-Garcia J, Hindi N, Conceicao M, Sala M, Ugalde A, Lopez-Pousa A, et al.
Eur J Cancer
. 2024 Aug;
209:114270.
PMID: 39142211
Purpose: Prognostic biomarkers remain necessary in sporadic desmoid tumor (DT) because the clinical course is unpredictable. DT location along with gene expression between thoracic and abdominal wall locations was analyzed....
2.
Alba-Bernal A, Godoy-Ortiz A, Dominguez-Recio M, Lopez-Lopez E, Quiros-Ortega M, Sanchez-Martin V, et al.
NPJ Breast Cancer
. 2024 May;
10(1):36.
PMID: 38750090
Early breast cancer patients often experience relapse due to residual disease after treatment. Liquid biopsy is a methodology capable of detecting tumor components in blood, but low concentrations at early...
3.
Jimenez-Rodriguez B, Alba-Bernal A, Lopez-Lopez E, Quiros-Ortega M, Carbajosa G, Garrido-Aranda A, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613590
Breast cancer (BC) is the most prevalent cancer in women. While usually detected when localized, invasive procedures are still required for diagnosis. Herein, we developed a novel ultrasensitive pipeline to...
4.
Apolonio J, Dias J, Fernandes M, Komosa M, Lipman T, Zhang C, et al.
Clin Epigenetics
. 2022 Dec;
14(1):178.
PMID: 36529814
Background: Breast cancer (BC) is the most frequently diagnosed cancer and a leading cause of death among women worldwide. Early BC is potentially curable, but the mortality rates still observed...
5.
Moura D, Pena-Chilet M, Cordero Varela J, Alvarez-Alegret R, Agra-Pujol C, Izquierdo F, et al.
Mol Oncol
. 2021 May;
15(12):3691-3705.
PMID: 33983674
Predictive biomarkers of trabectedin represent an unmet need in advanced soft-tissue sarcomas (STS). DNA damage repair (DDR) genes, involved in homologous recombination or nucleotide excision repair, had been previously described...
6.
Diaz-Redondo T, Lavado-Valenzuela R, Jimenez B, Pascual T, Galvez F, Falcon A, et al.
Front Oncol
. 2019 Nov;
9:1178.
PMID: 31750258
Double blockade with pertuzumab and trastuzumab combined with chemotherapy is the standard neoadjuvant treatment for HER2-positive early breast cancer. Data derived from clinical trials indicates that the response rates differ...
7.
Rodriguez B, Cordoba G, Aranda A, Alvarez M, Vicioso L, Perez C, et al.
J Clin Med
. 2019 Aug;
8(8).
PMID: 31394872
Circulating tumor DNA (ctDNA) has emerged as a non-invasive "liquid biopsy" for early breast cancer diagnosis. We evaluated the suitability of ctDNA analysis in the diagnosis of early breast cancer...
8.
Garcia-Alvarez L, Sanz M, Marin M, Farinas M, Montejo M, Goikoetxea J, et al.
J Antimicrob Chemother
. 2019 Mar;
74(6):1768.
PMID: 30869125
No abstract available.
9.
Garcia-Alvarez L, Sanz M, Marin M, Farinas M, Montejo M, Goikoetxea J, et al.
J Antimicrob Chemother
. 2019 Feb;
74(6):1713-1717.
PMID: 30789210
Objectives: Tropheryma whipplei has been detected in 3.5% of the blood culture-negative cases of endocarditis in Spain. Experience in the management of T. whipplei endocarditis is limited. Here we report...
10.
Santonja A, Sanchez-Munoz A, Lluch A, Chica-Parrado M, Albanell J, Chacon J, et al.
Oncotarget
. 2018 Jun;
9(41):26406-26416.
PMID: 29899867
Triple negative breast cancer (TNBC) is a heterogeneous disease with distinct molecular subtypes that differentially respond to chemotherapy and targeted agents. The purpose of this study is to explore the...